The DEEP project has received research funding from the European Union under the 7th Framework Programme
4th DEEP Scientific Open Meeting (Padua 2016)
Session II
MANAGEMENT OF THALASSAEMIA AND HAEMOGLOBINOPATHIES: AN ONGOING CHALLENGE
Deferiprone investigational pathway: beyond thalassaemia and haemoglobinopathies by Michael Spino, President of ApoPharma Inc., Canada
The use of deferiprone (Ferriprox™) in thalassemia was […]
4th DEEP Scientific Open Meeting (Padua 2016)
Session I
CHALLENGES AND OPPORTUNITIES OF CONDUCTING CLINICAL TRIALS IN PAEDIATRICS
Clinical research: where are we now with the new CT Regulation by Prof. Hugo Devlieger, DEEP Ethics Board Member, Department of Development and Regeneration […]